MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. (Q38963454)
Jump to navigation
Jump to search
scientific article published on January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. |
scientific article published on January 2014 |
Statements
1 reference
MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. (English)
1 reference
C Gao
1 reference
F H Peng
1 reference
L K Peng
1 reference
1 January 2014
1 reference
Identifiers
1 reference